{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:14:37Z","timestamp":1783473277325,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hubei Provincial Natural Science Foundation of China","award":["2025AFD611"],"award-info":[{"award-number":["2025AFD611"]}]},{"name":"Scientific ResearchProjects of Hubei Cancer Hospital","award":["2025HBCHYN31"],"award-info":[{"award-number":["2025HBCHYN31"]}]},{"name":"Research Projects of Biomedical Center of Hubei Cancer Hospital","award":["2022SWZX25"],"award-info":[{"award-number":["2022SWZX25"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00829-w","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:34:27Z","timestamp":1778747667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulated competitive splicing between circular and linear RNAs characterizes hepatocellular carcinoma tumorigenesis and recurrence"],"prefix":"10.1186","volume":"21","author":[{"given":"Sunlu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"829_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"829_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353.","journal-title":"Int J Cancer"},{"key":"829_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ajpath.2022.02.004","volume":"192","author":"L Pham","year":"2022","unstructured":"Pham L, et al. The Functional Roles of Immune Cells in Primary Liver Cancer. Am J Pathol. 2022;192:826\u201336.","journal-title":"Am J Pathol"},{"key":"829_CR4","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.3748\/wjg.v20.i20.5935","volume":"20","author":"A Colecchia","year":"2014","unstructured":"Colecchia A, et al. Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol. 2014;20:5935\u201350.","journal-title":"World J Gastroenterol"},{"key":"829_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-021-01145-8","volume":"14","author":"H Shen","year":"2021","unstructured":"Shen H, et al. Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer. J Hematol Oncol. 2021;14:134.","journal-title":"J Hematol Oncol"},{"key":"829_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","volume":"505","author":"L Chen","year":"2021","unstructured":"Chen L, Shan G. CircRNA in cancer: Fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49\u201357.","journal-title":"Cancer Lett"},{"key":"829_CR7","doi-asserted-by":"publisher","first-page":"215810","DOI":"10.1016\/j.canlet.2022.215810","volume":"544","author":"J Li","year":"2022","unstructured":"Li J, et al. CircRNAs in lung cancer- role and clinical application. Cancer Lett. 2022;544:215810.","journal-title":"Cancer Lett"},{"key":"829_CR8","doi-asserted-by":"publisher","first-page":"e13143","DOI":"10.1111\/cpr.13143","volume":"54","author":"W Xiao","year":"2021","unstructured":"Xiao W, et al. Circular RNAs in cell cycle regulation: Mechanisms to clinical significance. Cell Prolif. 2021;54:e13143.","journal-title":"Cell Prolif"},{"key":"829_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13059-019-1685-4","volume":"20","author":"W-C Liang","year":"2019","unstructured":"Liang W-C, et al. Translation of the circular RNA circ\u03b2-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol. 2019;20:84.","journal-title":"Genome Biol"},{"key":"829_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41392-023-01559-5","volume":"8","author":"J Jing","year":"2023","unstructured":"Jing J, et al. Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies. Signal Transduct Target Ther. 2023;8:315.","journal-title":"Signal Transduct Target Ther"},{"key":"829_CR11","doi-asserted-by":"publisher","first-page":"e18761429310703","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi B, et al. Mechanism, Potential, and Concerns of Immunotherapy for Hepatocellular Carcinoma and Liver Transplantation. Curr Mol Pharmacol. 2024;17:e18761429310703.","journal-title":"Curr Mol Pharmacol"},{"key":"829_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/0113892029313473240919105819","volume":"26","author":"X He","year":"2025","unstructured":"He X, et al. CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer. Curr Genomics. 2025;26:225\u201343.","journal-title":"Curr Genomics"},{"key":"829_CR13","first-page":"e18761429358008","volume":"17","author":"W Xu","year":"2024","unstructured":"Xu W, Liao S, Hu Y, Huang Y, Zhou J. Upregulation of miR-3130-5p Enhances Hepatocellular Carcinoma Growth by Suppressing Ferredoxin 1: miR-3130-5p Enhances HCC Growth via Inhibiting FDX1. Curr Mol Pharmacol. 2024;17:e18761429358008.","journal-title":"Curr Mol Pharmacol"},{"key":"829_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-022-01619-4","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, et al. CircGPR137B\/miR-4739\/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma. Mol Cancer. 2022;21:149.","journal-title":"Mol Cancer"},{"key":"829_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13046-022-02558-0","volume":"41","author":"X Liu","year":"2022","unstructured":"Liu X, et al. SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis. J Exp Clin Cancer Res. 2022;41:353.","journal-title":"J Exp Clin Cancer Res"},{"key":"829_CR16","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41556-022-00913-z","volume":"24","author":"JJ Chan","year":"2022","unstructured":"Chan JJ, et al. Pan-cancer pervasive upregulation of 3\u2019 UTR splicing drives tumourigenesis. Nat Cell Biol. 2022;24:928\u201339.","journal-title":"Nat Cell Biol"},{"key":"829_CR17","doi-asserted-by":"publisher","first-page":"114114","DOI":"10.1016\/j.addr.2022.114114","volume":"182","author":"K Zhang","year":"2022","unstructured":"Zhang K, et al. The role of RNA binding proteins in hepatocellular carcinoma. Adv Drug Deliv Rev. 2022;182:114114.","journal-title":"Adv Drug Deliv Rev"},{"key":"829_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13046-025-03395-7","volume":"44","author":"X Ren","year":"2025","unstructured":"Ren X, Yang W, Yan X, Zhang H. Exploring RNA binding proteins in hepatocellular carcinoma: insights into mechanisms and therapeutic potential. J Exp Clin Cancer Res. 2025;44:130.","journal-title":"J Exp Clin Cancer Res"},{"key":"829_CR19","doi-asserted-by":"publisher","first-page":"e2305902","DOI":"10.1002\/advs.202305902","volume":"11","author":"J Li","year":"2024","unstructured":"Li J, et al. A Mammalian Conserved Circular RNA CircLARP1B Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism. Adv Sci (Weinh). 2024;11:e2305902.","journal-title":"Adv Sci (Weinh)"},{"key":"829_CR20","doi-asserted-by":"publisher","first-page":"e03851","DOI":"10.1002\/advs.202503851","volume":"12","author":"J Shi","year":"2025","unstructured":"Shi J, et al. m6A-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. Adv Sci (Weinh). 2025;12:e03851.","journal-title":"Adv Sci (Weinh)"},{"key":"829_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13046-023-02657-6","volume":"42","author":"J Wei","year":"2023","unstructured":"Wei J, et al. Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression. J Exp Clin Cancer Res. 2023;42:86.","journal-title":"J Exp Clin Cancer Res"},{"key":"829_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41392-022-01275-6","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen X, et al. circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p-PTEN-AKT signaling. Signal Transduct Target Ther. 2023;8:67.","journal-title":"Signal Transduct Target Ther"},{"key":"829_CR23","doi-asserted-by":"publisher","first-page":"e2306915","DOI":"10.1002\/advs.202306915","volume":"11","author":"X Hu","year":"2024","unstructured":"Hu X, et al. Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21-Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis. Adv Sci (Weinh). 2024;11:e2306915.","journal-title":"Adv Sci (Weinh)"},{"key":"829_CR24","doi-asserted-by":"publisher","first-page":"112898","DOI":"10.1016\/j.yexcr.2021.112898","volume":"409","author":"Y Liang","year":"2021","unstructured":"Liang Y, Fan Y, Liu Y, Fan H. HNRNPU promotes the progression of hepatocellular carcinoma by enhancing CDK2 transcription. Exp Cell Res. 2021;409:112898.","journal-title":"Exp Cell Res"},{"key":"829_CR25","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1038\/s41388-021-01867-6","volume":"40","author":"X Wang","year":"2021","unstructured":"Wang X, Dong J, Li X, Cheng Z, Zhu Q. CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma. Oncogene. 2021;40:4338\u201351.","journal-title":"Oncogene"},{"key":"829_CR26","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.30039","volume":"68","author":"E Ko","year":"2018","unstructured":"Ko E, et al. Oxidatively Modified Protein-Disulfide Isomerase-Associated 3 Promotes Dyskerin Pseudouridine Synthase 1-Mediated Malignancy and Survival of Hepatocellular Carcinoma Cells. Hepatology. 2018;68:1851\u201364.","journal-title":"Hepatology"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00829-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00829-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00829-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:22:56Z","timestamp":1783470176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00829-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00829-w","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}